{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:49:14Z","timestamp":1784612954106,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Implantation of drug eluting stents (DES) is the mainstay treatment for patients requiring percutaneous coronary intervention (PCI). The polymer coating of DES has been associated with inflammatory response, increased arterial injury and long-term in-stent restenosis and thrombosis. Polymer-free stents (PFS) were designed to overcome limitations of polymer-coated stents (PCS). Our aim was to compare clinical outcomes of patients undergoing PCI with PFS versus contemporary PCS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a prospective, open-label registry study enrolling consecutive all-comers patients admitted to a single center and undergoing PCI using contemporary DES. Clinical outcomes were compared between patients treated with PFS and PCS. The primary endpoint was target lesion revascularization (TLR) at 12 months. Subgroup analyses were conducted for diabetic and nondiabetic patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Overall, 1664 patients were included: 928 (55.8%) of which were treated with PFS and 736 (44.2%) with PCS for 2046 and 1462 lesions, respectively. At 12 months, TLR rates were not significantly different between the groups (1.7% vs. 2.3% for PFS and PCS, respectively, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.48). The use of PFS did not improve clinical outcomes among diabetic patients in comparison with PCS. Target vessel revascularization and major adverse cardiac events rates were also similar between groups, regardless of diabetes status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Newer generation DES offer excellent results in diabetic and nondiabetic patients without significant differences in outcomes between PCS and PFS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mca.0000000000001143","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T06:00:07Z","timestamp":1658815207000},"page":"354-361","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Does the use of polymer-free drug eluting stents improve clinical outcomes of patients undergoing percutaneous coronary interventions?"],"prefix":"10.1097","volume":"33","author":[{"given":"Itamar","family":"Loewenstein","sequence":"first","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviram","family":"Hochstadt","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Merdler","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Chorin","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atalia","family":"Wenkert","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonatan","family":"Moshkovits","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Erez","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Toledano","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Arbel","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Halkin","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Ben-Shoshan","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Finkelstein","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Banai","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayan","family":"Konigstein","sequence":"additional","affiliation":[{"name":"Tel-Aviv Medical Center"},{"name":"Sackler Faculty of Medicine, Tel-Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa0706258","article-title":"A comparison of bare-metal and drug-eluting stents for off-label indications.","volume":"358","author":"Marroquin","year":"2008","journal-title":"N Engl J Med"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of \u2018new-generation\u2019 drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur Heart J"},{"key":"R3-20250729","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/S0140-6736(19)30474-X","article-title":"Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.","volume":"393","author":"Piccolo","year":"2019","journal-title":"Lancet"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing.","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent.","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jacc.2011.12.009","article-title":"A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.","volume":"59","author":"Carri\u00e9","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk.","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jacc.2020.05.026","article-title":"10-year outcomes from a randomized trial of polymer-free versus durable polymer drug-eluting coronary stents.","volume":"76","author":"Kufner","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcin.2015.09.020","article-title":"A randomized comparison of reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus: the RESERVOIR clinical trial.","volume":"9","author":"Romaguera","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/CIRCULATIONAHA.118.037707","article-title":"Randomized all-comers evaluation of a permanent polymer zotarolimus-eluting stent versus a polymer-free amphilimus-eluting stent.","volume":"139","author":"Rozemeijer","year":"2019","journal-title":"Circulation"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1745-6215-12-106","article-title":"Through the looking glass: understanding non-inferiority.","volume":"12","author":"Schumi","year":"2011","journal-title":"Trials"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.carrev.2019.10.017","article-title":"Polymer-free vs. polymer-coated drug-eluting stents for the treatment of coronary artery disease: a meta-analysis of 16 randomized trials.","volume":"21","author":"Verdoia","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"e15217","DOI":"10.1097\/MD.0000000000015217","article-title":"Polymer-free drug-eluting stents versus permanent polymer drug-eluting stents.","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.carrev.2018.12.010","article-title":"Biodegradable-polymer versus polymer-free drug-eluting stents for the treatment of coronary artery disease.","volume":"20","author":"Nogic","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials.","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.100.12.1285","article-title":"Prognostic value of the modified American College of Cardiology\/American Heart Association Stenosis Morphology Classification for long-term angiographic and clinical outcome after coronary stent placement.","volume":"100","author":"Kastrati","year":"1999","journal-title":"Circulation"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"e002943","DOI":"10.1161\/CIRCINTERVENTIONS.115.002943","article-title":"Stent polymers.","volume":"9","author":"Rizas","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/01.CIR.0000041632.02514.14","article-title":"Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate\u2013eluting polymer stent system in humans.","volume":"106","author":"Virmani","year":"2002","journal-title":"Circulation"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2015.01.047","article-title":"Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention.","volume":"65","author":"Kazi","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1021\/acs.bioconjchem.5b00192","article-title":"Polymer-free drug-eluting stents: an overview of coating strategies and comparison with polymer-coated drug-eluting stents.","volume":"26","author":"Chen","year":"2015","journal-title":"Bioconjug Chem"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"e007311","DOI":"10.1161\/CIRCINTERVENTIONS.118.007311","article-title":"Safety and efficacy of polymer-free drug-eluting stents.","volume":"12","author":"Chiarito","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2017.06.028","article-title":"Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus.","volume":"245","author":"Godino","year":"2017","journal-title":"Int J Cardiol"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jcin.2015.09.008","article-title":"Polymer-free biolimus A9-coated stents in the treatment of De Novo coronary lesions: 4- and 12-month angiographic follow-up and final 5-year clinical outcomes of the prospective, multicenter BioFreedom FIM clinical trial.","volume":"9","author":"Costa","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/hrt.2005.075960","article-title":"Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.","volume":"92","author":"Hong","year":"2006","journal-title":"Heart"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.jcin.2018.09.033","article-title":"Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: analysis from the BIONICS randomized trial.","volume":"11","author":"Konigstein","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R27-20250729","first-page":"961","article-title":"Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.","volume":"38","author":"Naber","year":"2017","journal-title":"Eur Heart J"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/CIRCINTERVENTIONS.109.891192","article-title":"New drug-eluting stents.","volume":"3","author":"Abizaid","year":"2010","journal-title":"Circ Cardiovas Interv"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T18:04:31Z","timestamp":1753812271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000001143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000001143","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,8]]}}}